Pfiz­er shares surge on pos­i­tive im­pact of their mR­NA Covid-19 vac­cine — part­nered with BioN­Tech — in an ear­ly-stage study

Pfiz­er and their part­ners at the mR­NA spe­cial­ist BioN­Tech have pub­lished the first glimpse of bio­mark­er da­ta from an ear­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.